You are here

ViaCyte

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Xconomy

Flag link:

ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later

ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later

Xconomy

clinical trials

Flag link:

CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy

CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy

Xconomy

CRISPR Therapeutics

Flag link:

J&J, Viacyte team up on a potential stem cell therapy 'cure' for type 1 diabetes

J&J, Viacyte team up on a potential stem cell therapy 'cure' for type 1 diabetes

BioPharma Dive

type 1 diabetes

Flag link:

J&J pours another $20M into ViaCyte and sizes up its diabetes treatment

J&J pours another $20M into ViaCyte and sizes up its diabetes treatment

Fierce Biotech

Flag link: